Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary autologous bone marrow mononuclear cells for idiopathic dilated cardiomyopathy
2007-003088-36Phase 2Active
- Sponsor
- AININCAR
- Start
- Sep 2007
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone marrow mononuclear cells in idiopathic dilated cardiomyopathy (IDC) and dilated cardiomyopathy (DCM), sponsored by AININCAR. Primary endpoint: Improvement of left ventricular function at follow-up. Started Sep 2007; status: active.
02
Drugs
bone marrow mononuclear cells
03
Conditions
idiopathic dilated cardiomyopathy (IDC)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on 2007-003088-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003088-36.